Supplementary Figure S1 from Amplification of the <i>MET</i> Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

Abstract

&lt;p&gt;Supplementary Figure S1 - PDF file 158K, MET is not overexpressed in tumors which display KRAS mutations as a mechanism of secondary resistance to EGFR targeted monoclonal antibodies&lt;/p&gt;